105
Participants
Start Date
November 30, 2016
Primary Completion Date
June 30, 2017
Study Completion Date
August 31, 2017
Gemcabene
Two 300 mg tablets and 1 placebo tablet administered orally, once daily for 12 weeks.
Placebo
Three placebo tablets administered orally once daily for 12 weeks.
Mid-Hudson Medical Research, New Windsor
Rochester Clinical Research, Inc., Rochester
Green and Seidner Family Practice Associates, Lansdale
Progressive Medical Research, Port Orange
Jacksonville Center for Clinical Research, Jacksonville
Meridien Research, Inc., Maitland
Excel Medical Clinical Trials, Boca Raton
Health Awareness, Inc., Jupiter
Atlantic Clinical Research Collaborative- Cardiology, Atlantis
Varkey Medical, Tampa
Central Research Associates, Inc., Birmingham
L-MARC, Louisville
Sterling Research Group, Ltd., Cincinnati
Sentral Clinical Research Services, Cincinnati
Sterling Research Group, Ltd., Cincinnati
Midwest Institute for Clinical Research, Indianapolis
Evanston Premier Healthcare Research, LLC, Evanston
Associates in Medicine, Houston
Sugar Lakes Family Practice, Sugar Land
Diagnostics Research Grup, San Antonio
National Research Institute, Los Angeles
Westside Medical Associates of Los Angeles, Beverly Hills
National Research Institute, Huntington Park
National Research Institute, Richmond
Lead Sponsor
NeuroBo Pharmaceuticals Inc.
INDUSTRY